benefits and drawbacks of the ipss-m
Published 1 year ago • 106 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:23
benefits, applicability & uses of the ipss-m in mds
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
1:14
how the ipss-m score helps personalizing treatment & combination therapies in hr-mds
-
2:01
updates in mds diagnosis and prognosis with the ipss-m: personalized medicine in 2023
-
1:45
evaluating ipss-r and ipss-m in patients with hr-mds enrolled in stimulus-mds1 and stimulus-mds2
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:30
the prognostic value of patient-reported outcomes in mds
-
0:59
the safety and efficacy of etavopivat in scd
-
1:46:07
hematology lecture
-
5:42
complement inhibition with iptacopan has high efficacy in pnh: insights from apply and appoint
-
21:38
drawing the line: the rationale behind blood tube collection order
-
1:59
topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
-
1:16
eha/ebmt consensus grading of icaht
-
4:44
keynote-183 and optimismm: creating new standards of care for r/r mm
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
3:29
ptcy as gvhd prophylaxis: side effects, optimizing the dose, and the effect of dose-reduction
-
2:04
state-of-the-art treatment for hr-mds
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
4:48
an insight into the management of cytopenias in mf
-
1:51
targeting complement to treat pnh and other hematologic diseases
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds